Contemporary Pediatrics week in review: Maternal RSV vaccine approval, pediatric firearm death rates, and more

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, August 21 - Friday, August 25, 2023) and click each link to read and watch anything you may have missed.

1.) FDA approves Pfizer’s maternal vaccine to prevent RSV in infants

Approved for use at 32 weeks' through 36 weeks' gestation, Pfizer’s maternal respiratory syncytial vaccine (Abrysvo), is delivered through a single dose injection to the muscle and is the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD because of RSV in infants (birth to 6 months).

Click here for the full article.

2.) What Pfizer's maternal RSV vaccine means for the infant population

To further break down Pfizer's RSV maternal vaccine approval, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses what the vaccine means for infants ahead of the traditional RSV season.

Click here to watch the full interview.

3.) Firearm deaths among children rose again in 2021, disparities widened

In 2021, firearm deaths continued to be the leading cause of death for US children, with further worsening disparities noticed, according to a study published in Pediatrics.

Click here for the full article.

4.) More screen time at age 1 year associated with developmental delays at 2, 4 years

Study authors concluded that developmental delay domains should be separately considered when discussing screen time and potential delays in childhood development.

Click here for the full article.

5.) Why a correctly-fitting blood pressure cuff is important for children

In this Contemporary Pediatrics® interview, Tammy Brady, MD, PhD, explains how an incorrectly-fitting blood pressure cuff can lead to the wrong diagnosis in the pediatric population, and what tips to look for when shopping for cuffs currently on the market.

Click here to watch the full interview.